Comparison of cytotoxicities and anti-allergic effects of topical ocular dual-action anti-allergic agents.

Alcaftadine seems to have less side effects and better therapeutic effects than the other two anti-allergic agents tested. It may be more beneficial to use less toxic agents for patients with ocular surface risk factors or presumed symptoms of toxicity.